It's Time to Put the Term "Pulmonary Vasodilators" to Rest.
作者信息
Rubin Lewis J
机构信息
Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
出版信息
JACC Basic Transl Sci. 2021 Nov 22;6(11):870-871. doi: 10.1016/j.jacbts.2021.10.007. eCollection 2021 Nov.
Abstract
摘要
相似文献
1
It's Time to Put the Term "Pulmonary Vasodilators" to Rest.
JACC Basic Transl Sci. 2021 Nov 22;6(11):870-871. doi: 10.1016/j.jacbts.2021.10.007. eCollection 2021 Nov.
2
β-Arrestin-Mediated Angiotensin II Type 1 Receptor Activation Promotes Pulmonary Vascular Remodeling in Pulmonary Hypertension.
JACC Basic Transl Sci. 2021 Nov 22;6(11):854-869. doi: 10.1016/j.jacbts.2021.09.006. eCollection 2021 Nov.
3
Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.
Cell Signal. 2021 Jun;82:109967. doi: 10.1016/j.cellsig.2021.109967. Epub 2021 Feb 25.
4
Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
J Biol Chem. 2014 Oct 10;289(41):28271-83. doi: 10.1074/jbc.M114.585067. Epub 2014 Aug 28.
5
beta-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress.
Sci Signal. 2010 Jun 8;3(125):ra46. doi: 10.1126/scisignal.2000769.
6
β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
J Biol Chem. 2015 Aug 21;290(34):21131-21140. doi: 10.1074/jbc.M115.644450. Epub 2015 Jul 8.
7
Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.
Pharmacol Res. 2017 Sep;123:40-50. doi: 10.1016/j.phrs.2017.06.013. Epub 2017 Jun 23.
8
Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signaling.
Pharmacol Res. 2021 Dec;174:105943. doi: 10.1016/j.phrs.2021.105943. Epub 2021 Oct 15.
9
Comparative analyses of downstream signal transduction targets modulated after activation of the AT1 receptor by two β-arrestin-biased agonists.
Front Pharmacol. 2015 Jul 1;6:131. doi: 10.3389/fphar.2015.00131. eCollection 2015.
10
Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor.
Hypertension. 2016 Dec;68(6):1365-1374. doi: 10.1161/HYPERTENSIONAHA.116.08118. Epub 2016 Oct 3.
引用本文的文献
1
Cellular senescence in adult pulmonary hypertension: current state and future challenges.
Eur Respir Rev. 2025 Sep 17;34(177). doi: 10.1183/16000617.0030-2025. Print 2025 Jul.
2
Systemic sclerosis.
Lancet. 2023 Jan 28;401(10373):304-318. doi: 10.1016/S0140-6736(22)01692-0. Epub 2022 Nov 25.
本文引用的文献
1
β-Arrestin-Mediated Angiotensin II Type 1 Receptor Activation Promotes Pulmonary Vascular Remodeling in Pulmonary Hypertension.
JACC Basic Transl Sci. 2021 Nov 22;6(11):854-869. doi: 10.1016/j.jacbts.2021.09.006. eCollection 2021 Nov.
2
Sotatercept for the Treatment of Pulmonary Arterial Hypertension.
N Engl J Med. 2021 Apr 1;384(13):1204-1215. doi: 10.1056/NEJMoa2024277.
3
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
Circulation. 2005 Jun 14;111(23):3105-11. doi: 10.1161/CIRCULATIONAHA.104.488486. Epub 2005 Jun 6.
4
Pulmonary hypertension with special reference to the vasoconstrictive factor.
Br Heart J. 1958 Oct;20(4):557-70. doi: 10.1136/hrt.20.4.557.
5
The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects.
Circulation. 1958 Oct;18(4 Part 1):533-47. doi: 10.1161/01.cir.18.4.533.
6
Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery.
Am J Respir Cell Mol Biol. 2002 Feb;26(2):194-201. doi: 10.1165/ajrcmb.26.2.4695.
Zotero 插件